Show channels:
All channels
Bladder cancer
Brain and spinal
Breast cancer
Cervical
Colon & rectal
Dermatological
General Information
Gynecological
Head and Neck
Kidney/adrenal
Liver
Lung
Lymphoma
Multiple Myeloma
Myelodysplastic syndromes
Myeloproliferative disorders
Pancreas
Pediatric
Prostate
Sarcoma
Stomach
Testicular
Thyroid
Upper aerodigestive
Found 15807 articles
Fatty acid binding protein 7 may be a marker and therapeutic targets in clear cell renal cell carcinoma
The Cancer Genome Atlas Research Network (TCGA) database shows FABP6 and 7 as equally overexpressed in the FABP family.
»
11/15/18
Mifepristone inhibits non-small cell lung carcinoma cellular escape from DNA damaging cisplatin
CDDP killed the majority of cells.
»
11/15/18
LMO7 and LIMCH1 interact with LRIG proteins in lung cancer, with prognostic implications for early-stage disease.
LMO7 immunoreactivity shown to be negative prognostic factor in LRIG1 positive tumors.
»
08/20/18
Long noncoding RNA IGF2AS is acting as an epigenetic tumor suppressor in human prostate cancer.
IGF2 upregulation revered suppressing function of IGF2AS.
»
09/05/18
Tanshinone IIA inhibits cervix carcinoma stem cells migration and invasion via inhibiting YAP transcriptional activity.
Tanshinone IIA enhanced adriamycin sensitivity in CC stemness-like cells.
»
04/05/18
miR-146a controls immune response in the melanoma microenvironment.
miR-146a plays central role within STAT1/IFN-γ axis.
»
11/08/18
Prognostic impact of CDX2 in stage II colon cancer: results from two nationwide cohorts.
Independent prognostic impact of CDX2 on disease-free survival.
»
04/08/18
Denosumab and breast cancer risk in postmenopausal women: a population-based cohort study.
No relationship between increasing number of denosumab doses and breast cancer risk.
»
02/05/18
Survival of glioma patients in relation to mobile phone use in Denmark, Finland and Sweden.
No evidence of reduced survival among glioma patients in relation to previous mobile phone use.
»
07/06/18
YAP1 and COX2 Coordinately Regulate Urothelial Cancer Stem-like Cells.
Preclinical rationale to target the COX2 and YAP1 pathways concurrently.
»
03/24/17
< Prev
Next >